PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Will Congress Enact Curbs on Drug Pricing?

PIE is Good for You: Drive Patient Access by Embracing FDA's Final Guidance

Digital Therapeutics Can Break Down Barriers to Innovation to Benefit Patients

Medical Affairs
Pharma Medical Affairs: A Blueprint for Future
Changing customer preferences and a growing need for specialized knowledge are challenging the traditional scope of the medical affairs function. Here are six ways pharma MA departments can drive more collaborative relationships with caregivers.
... /Read more/
Advertisement
Exclusive Interviews from eyeforpharma
Gather insights from featured industry professionals on organizational DNA and empathy in drug development
Watch Videos
Letter from the Editor
Pharm Exec 50 Hints to Rest of '19
Our latest report of the top 50 biopharma companies provides a nice springboard to the coverage we have in store for you in the year's second half.
... /Read more/
Q&A
On a Double Mission: Chris Round, Merck KGaA, Darmstadt, Germany
Chris Round sat down with Pharm Exec to talk how new treatments such as Mavenclad and Bavencio are positioned to advance the company's "double mission;" what differentiates Merck KGaA, Darmstadt, Germany in the immuno-oncology space; and how his leadership approach has evolved in a changing industry.
... /Read more/
ADVERTISEMENT
Calendar
 
/ Direct-to-Patient Clinical Trials – 8/8–8/9 /
 
/ 13th Annual Forum on Transparency & Aggregate Spend – 8/12–8/14 /
 
/ 340B Manufacturer Summit – 8/20–8/21 /
 
/ 4th Annual Partnering with IDNs BioPharma Strategy Summit – 8/21–8/22 /
 
 
Pharma50
Pharm Exec's Top 50 Companies 2019
Our 19th annual listing reveals some interesting maneuvering of ranks, as companies focus on diversification, big-brand expansions, and positioning a new wave of products to compete in an advancing but complex future treatment market.
... /Read more/
The Future of the Life Sciences Executive
The Pharm Exec Podcast: Episode 34
Cameron Turtle, Chief Business Officer of Eidos Therapeutics, Robin Toft, Founder and CEO of The Toft Group Executive Search and Sabrina Johnson, President and CEO, Daré Bioscience join Pharm Exec editors to talk about the future of the life sciences executive.
... /Read more/
update my profile / advertise with us / print & digital subscribe / visit pharmexec.com